NEK2 and Miyoshi myopathy: Our recent mechanistic studies have demonstrated that isatuximab triggers direct lysosome-mediated cell death, specifically in MM cells with chromosome 1q gain or amplification (1q+), characterized by FOXM1, NEK2, and UBE2T upregulation [16].